• 8295 Citations
  • 51 h-Index
1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Courtney V Fletcher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • A Compartmental Analysis of HIV Reservoirs and Immune Reconstitution

    Fletcher, C. V., Haase, A. T., Schacker, T., Reilly, C. S. & Stevenson, M.

    National Institutes of Health

    9/30/0812/31/14

    Project: Research project

  • PEDIATRIC AIDS CLINICAL TRIALS GROUP

    Fletcher, C. V., Hollinger, F. B., Rosenblatt, H. & Shearer, W.

    National Institutes of Health

    9/30/882/28/07

    Project: Research project

  • Research Output

    Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral Therapy

    Godfrey, C., Hughes, M. D., Ritz, J., Coelho, L., Gross, R., Salata, R., Mngqibisa, R., Wallis, C. L., Mumbi, M. E., Matoga, M., Poongulali, S., Van Schalkwyk, M., Hogg, E., Fletcher, C. V., Grinsztejn, B. & Collier, A. C., Jun 1 2020, In : Journal of acquired immune deficiency syndromes (1999). 84, 2, p. 203-207 5 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review

    Havens, J. P., Podany, A. T., Scarsi, K. K. & Fletcher, C. V., Feb 1 2020, In : Clinical Pharmacokinetics. 59, 2, p. 137-154 18 p.

    Research output: Contribution to journalReview article

  • 1 Scopus citations

    Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics

    Dyavar, S. R., Mykris, T. M., Winchester, L. C., Scarsi, K. K., Fletcher, C. V. & Podany, A. T., Dec 1 2020, In : Scientific reports. 10, 1, 12565.

    Research output: Contribution to journalArticle

    Open Access
  • High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

    The AIDS Clinical Trials Group and the Tuberculosis Trials Consortium, Mar 2020, In : Contemporary Clinical Trials. 90, 105938.

    Research output: Contribution to journalArticle